Over 300 Colorado Auctions End Tomorrow 05/12 - Bid Now
Over 150 Total Lots Up For Auction at Two Locations - PA 05/15, NY 05/20

Advanced Radiation Therapy picks Theragenics to distribute AccuBoost technology

Press releases may be edited for formatting or style | August 03, 2015

Mr. Tarallo continued, "Our brachytherapy expertise complements their technical system expertise perfectly. Our established channels in the radiation oncology market segment will make AccuBoost more widely available and expand treatment choices, a plus for breast cancer patients."

About Advanced Radiation Therapy

stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats

Advanced Radiation Therapy is a key innovator in partial breast brachytherapy through its AccuBoost Technology. The non-invasive, mammography-guided breast irradiation technology was developed and optimized specifically for treatment of the breast. AccuBoost can be found at select radiation oncology centers across the country.

About Theragenics

Theragenics Corporation® is a medical device company focusing on the cancer treatment and surgical products market. Theragenics' brachytherapy business manufactures and sells products used primarily in the minimally invasive treatment of localized prostate cancer (www.theragenicsbrachy.com) and breast cancer. The surgical products business (www.cpmedical.com, www.galtmedical.com, www.needletech.com) manufactures and distributes wound closure, vascular access, and specialty needle products. The surgical segment serves a number of markets including interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery.

Back to HCB News

You Must Be Logged In To Post A Comment